- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Exhibit 32.2
CERTIFICATION OF
PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT of 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Kathleen P. Bloch, the Interim Chief Financial Officer of CytoSorbents Corporation, hereby certify, that, to my knowledge:
1. | The Quarterly Report on Form 10-Q for the quarter ending March 31, 2023, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
2. | The information contained in such Quarterly Report on Form 10-Q for the quarter ending March 31, 2023, fairly presents, in all material respects, the financial condition and results of operations of CytoSorbents Corporation. |
| | | |
| | ||
Date: May 2, 2023 | |
| |
| | | |
CYTOSORBENTS CORPORATION | | | |
| | | |
By: | /s/ Kathleen P. Bloch | | |
Kathleen P. Bloch | | | |
Interim Chief Financial Officer | | |